Consumer Perception and Behavior studies

Consumer perception studies aim to assess how product design, product information (e.g. labeling, modified risk information) and intended product use is perceived by users and non-users in order to ensure that the product appeals only to the target audience (i.e. existing adult consumers). These studies also investigate the potential effects of the product on public health overall. The study outcomes provide insights into the intention to use (try) the product, intention to quit smoking, perceived risks from the product, comprehension of the product characteristics and so on. Behavior studies aim to understand consumption and use patterns of the products under real-world like conditions.

Glass with paper
step-section

Consumer perception study in regulatory framework

Consumer perception studies may be performed in the context of specific regulatory frameworks for the RRP*. Some public health authorities, such as the US-FDA, have put in place a framework that enables communication to reduced-exposure and reduced-risk of tobacco products. As a part of this framework, the US-FDA requires the perception studies to the applicant of Modified Risk Tobacco Product Applications (MRTPA) to demonstrate that:

Testing of actual consumer perception shows that, as the applicant proposes to label and market the product, consumers will not be misled into believing that the product is or has been demonstrated to be less harmful or presents or has been demonstrated to present less of a risk of disease than one or more other commercially marketed tobacco products’ (US-FDA's draft guidance on MRTPA).

In this section, we introduce some of the consumer perception studies we have performed.

Assessments for product messages

Assuming our product has been approved by the authorities as a product that has been scientifically proven to have a reduced risk potential, we create drafted messages attached to the products, only for the study. After participants read these messages, they are asked about their comprehension and perception of the products with questionnaires.

Example of messages

Claim

Research shows that switching completely from cigarettes to electronic cigarettes can reduce the risks of developing tobacco-related diseases such as lung cancer, respiratory and heart disease.

Disclaimer

- Reduced risk of developing tobacco-related disease does not mean risk free.
- Electronic cigarettes contain nicotine. Nicotine is addictive.
- Electronic cigarettes are meant for adult smokers.
- Electronic cigarettes are not meant for non-smokers or smokers who intend to quit.
- The best way to reduce your risk of tobacco-related diseases is to completely quit tobacco use.

step-5-section-3

Comprehension

We check whether the messages correctly communicate risks and benefits of the products, including:

  • The product’s potential of reducing risks/exposure
  • That product is not risk-free
  • That nicotine is addictive etc.

 

Risk perception

We also need to check how risks about the product are perceived. For example, if scientific data shows that risks from RRP* use are rated between smoking and cessation, this relationship should be correctly understood by the readers.

Intention to use product and intention to quit

In addition, we assess intention to use the product by adult smokers and non-smokers.

RRP* is an alternative choice for existing adult smokers, so risk-related claims messages should not attract non-smokers (including youth). In this context, it is important to assess whether various people such as current smokers, non-smokers, and former smokers show desire to use the product, after reading the messages.

Moreover, for smokers who are willing to quit smoking, we check that the messages do not change such willingness.

Link to related studies

GRID LIST
Poster
A quantitative assessment of statements communicating the reduced risk potential of electronic cigarettes and tobacco vapor products: Impacts on UK adult's perceptions of vaping products and their comprehension of the messages and risk perception of the product

JAPANESE ALCOHOL, NICOTINE & DRUG ADDICTION CONFERENCE 2020

Poster
Heated tobacco products
Product design
A quantitative assessment of statements communicating the reduced risk potential of electronic cigarettes and tobacco vapor products: Impacts on UK adult's perceptions of vaping products and their comprehension of the messages and risk perception of the product
Jun 2020

JAPANESE ALCOHOL, NICOTINE & DRUG ADDICTION CONFERENCE 2020

Poster
A quantitative assessment of statements communicating the reduced risk potential of electronic cigarettes and tobacco vapor products: Impacts on UK adult's perceptions of vaping products and their intention (or not) to use/ try them

JAPANESE ALCOHOL, NICOTINE & DRUG ADDICTION CONFERENCE 2020

Poster
Heated tobacco products
Product design
A quantitative assessment of statements communicating the reduced risk potential of electronic cigarettes and tobacco vapor products: Impacts on UK adult's perceptions of vaping products and their intention (or not) to use/ try them
Jun 2020

JAPANESE ALCOHOL, NICOTINE & DRUG ADDICTION CONFERENCE 2020

What are the consumer behavior assessments?

Given the concept of tobacco harm reduction, our RRP* needs to offer the potential to reduce the health risks of product use and be accepted by many smokers. Therefore, we believe that it is important to confirm user behavior before and after launching the products.

CONSUMER BEHAVIOR ASSESSMENTS

Product use behavior

Product use behavior study investigates how our consumers actually use the product.

This study assesses the patterns of product usage such as number and frequency of usage, combined usage with cigarettes, and for consumers who use the product, by conducting a survey. In addition, it is asked whether the product can be alternative of the cigarettes. Since the behavior may be changed after long-term usage, it is important to monitor patterns of usage in our customers not only before and just after the product is released, but also after the product is put on the market for a long time.

Link
Clinical studies
Link
How we assess RRP
Link
Product Design